Interactive Investor
>>

Oryzon Genomics SA (XMAD:ORY) Share Price

ORY

Oryzon Genomics SA

European company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XMAD

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics.

XMAD:ORY

ES0167733015

EUR

Loading...

Loading Comparison

Latest ORY News